🔸 Final Sofdra™ Labelling Discussions with FDA 🔸 #Botanix submitted the last label materials to the US FDA for Sofdra™ a pending prescription treatment for excessive underarm sweating. Labelling, the final step before anticipated Sofdra approval, involves wording of product information for patients and physicians. View the ASX release 👉 https://lnkd.in/gmMbtu6e $BOT #ASX #dermatology #pharmaceuticals #pharma #biotech #innovation #hyperhidrosis #launch
Great news Howie!
Well done!
Congratulations!
Congrats Howie!
Sales at REVIAN
1moCongrats to you and the team Howie! Full steam ahead